TreeWAS – Variant ID: rs16826005

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
N35.9 Urethral stricture, unspecified	0.057	0.943	0.000
N35 Urethral stricture	0.034	0.966	0.000
N35.8 Other urethral stricture	0.025	0.975	0.000
N35.1 Postinfective urethral stricture, not elsewhere classified	0.025	0.975	0.000
N35.0 Posttraumatic urethral stricture	0.025	0.975	0.000
N30-N39 Other diseases of urinary system	0.018	0.982	0.000
N32 Other disorders of bladder	0.016	0.984	0.000
N32.9 Bladder disorder, unspecified	0.016	0.984	0.000
N36 Other disorders of urethra	0.015	0.985	0.000
N34 Urethritis and urethral syndrome	0.015	0.985	0.000
N31 Neuromuscular dysfunction of bladder, not elsewhere classified	0.014	0.986	0.000
N37 Urethral disorders in diseases classified elsewhere	0.013	0.987	0.000
N33 Bladder disorders in diseases classified elsewhere	0.013	0.987	0.000
N36.8 Other specified disorders of urethra	0.013	0.987	0.000
N30 Cystitis	0.013	0.987	0.000
N32.1 Vesicointestinal fistula	0.012	0.987	0.000
N34.3 Urethral syndrome, unspecified	0.012	0.988	0.000
N32.4 Rupture of bladder, nontraumatic	0.012	0.988	0.000
N32.2 Vesical fistula, not elsewhere classified	0.012	0.988	0.000
N32.0 Bladder-neck obstruction	0.012	0.988	0.000
N30.8 Other cystitis	0.012	0.988	0.000
N32.8 Other specified disorders of bladder	0.012	0.988	0.000
N36.3 Prolapsed urethral mucosa	0.012	0.988	0.000
N31.2 Flaccid neuropathic bladder, not elsewhere classified	0.011	0.989	0.000
N36.9 Urethral disorder, unspecified	0.011	0.989	0.000
N36.1 Urethral diverticulum	0.011	0.989	0.000
N36.2 Urethral caruncle	0.011	0.989	0.000
N34.2 Other urethritis	0.011	0.989	0.000
N34.1 Nonspecific urethritis	0.011	0.989	0.000
N34.0 Urethral abscess	0.011	0.989	0.000
N36.0 Urethral fistula	0.011	0.989	0.000
N31.8 Other neuromuscular dysfunction of bladder	0.011	0.989	0.000
N31.1 Reflex neuropathic bladder, not elsewhere classified	0.010	0.990	0.000
N31.0 Uninhibited neuropathic bladder, not elsewhere classified	0.010	0.990	0.000
N30.1 Interstitial cystitis (chronic)	0.010	0.990	0.000
N33.8 Bladder disorders in other diseases classified elsewhere	0.010	0.990	0.000
N33.0 Tuberculous cystitis	0.010	0.990	0.000
N37.8 Other urethral disorders in diseases classified elsewhere	0.010	0.990	0.000
N37.0 Urethritis in diseases classified elsewhere	0.010	0.990	0.000
H43.1 Vitreous haemorrhage	0.000	0.990	0.010
N31.9 Neuromuscular dysfunction of bladder, unspecified	0.010	0.990	0.000
N30.4 Irradiation cystitis	0.009	0.991	0.000
N30.0 Acute cystitis	0.009	0.991	0.000
N30.3 Trigonitis	0.009	0.991	0.000
H43.8 Other disorders of vitreous body	0.000	0.991	0.009
H43 Disorders of vitreous body	0.000	0.991	0.009
N32.3 Diverticulum of bladder	0.008	0.992	0.000
H43.3 Other vitreous opacities	0.000	0.993	0.007
K57.2 Diverticular disease of large intestine with perforation and abscess	0.007	0.993	0.000
K57.9 Diverticular disease of intestine, part unspecified, without perforation or abscess	0.007	0.993	0.000
H43.2 Crystalline deposits in vitreous body	0.000	0.994	0.006
H43.0 Vitreous prolapse	0.000	0.994	0.006
N87.9 Dysplasia of cervix uteri, unspecified	0.006	0.994	0.000
N30.2 Other chronic cystitis	0.006	0.994	0.000
A41.9 Septicaemia, unspecified	0.000	0.994	0.006
K57 Diverticular disease of intestine	0.006	0.994	0.000
H43.9 Disorder of vitreous body, unspecified	0.000	0.994	0.005
T85 Complications of other internal prosthetic devices, implants and grafts	0.006	0.994	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.006	0.994	0.000
L60.0 Ingrowing nail	0.000	0.994	0.005
T85.8 Other complications of internal prosthetic devices, implants and grafts, not elsewhere classified	0.005	0.995	0.000
N92.1 Excessive and frequent menstruation with irregular cycle	0.005	0.995	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.995	0.005
E16.2 Hypoglycaemia, unspecified	0.000	0.995	0.005
N87.0 Mild cervical dysplasia	0.005	0.995	0.000
T85.2 Mechanical complication of intraocular lens	0.005	0.995	0.000
K57.1 Diverticular disease of small intestine without perforation or abscess	0.005	0.995	0.000
M06.9 Rheumatoid arthritis, unspecified	0.000	0.995	0.005
T85.4 Mechanical complication of breast prosthesis and implant	0.005	0.995	0.000
N30.9 Cystitis, unspecified	0.005	0.995	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.995	0.005
C34.9 Bronchus or lung, unspecified	0.000	0.995	0.005
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.995	0.005
N87 Dysplasia of cervix uteri	0.005	0.995	0.000
T85.1 Mechanical complication of implanted electronic stimulator of nervous system	0.004	0.996	0.000
T85.6 Mechanical complication of other specified internal prosthetic devices, implants and grafts	0.004	0.996	0.000
T85.3 Mechanical complication of other ocular prosthetic devices, imnplants and grafts	0.004	0.996	0.000
T85.9 Unspecified complication of internal prosthetic device, implant and graft	0.004	0.996	0.000
K57.5 Diverticular disease of both small and large intestine without perforation or abscess	0.004	0.996	0.000
K57.4 Diverticular disease of both small and large intestine with perforation and abscess	0.004	0.996	0.000
K57.0 Diverticular disease of small intestine with perforation and abscess	0.004	0.996	0.000
T85.0 Mechanical complication of ventricular intracranial (communicating) shunt	0.004	0.996	0.000
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.004	0.996	0.000
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.996	0.004
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.996	0.004
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.996	0.004
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.996	0.004
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.996	0.004
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.996	0.004
K57.8 Diverticular disease of intestine, part unspecified, with perforation and abscess	0.004	0.996	0.000
S42.20 Fracture of upper end of humerus (closed)	0.000	0.996	0.004
C34.3 Lower lobe, bronchus or lung	0.000	0.996	0.004
N87.2 Severe cervical dysplasia, not elsewhere classified	0.003	0.996	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.996	0.003
M10.96 Gout, unspecified (Lower leg)	0.003	0.996	0.000
C34 Malignant neoplasm of bronchus and lung	0.000	0.997	0.003
H40.0 Glaucoma suspect	0.000	0.997	0.003
A41 Other septicaemia	0.000	0.997	0.003
M10.99 Gout, unspecified (Site unspecified)	0.003	0.997	0.000
M06 Other rheumatoid arthritis	0.000	0.997	0.003
Z45.8 Adjustment and management of other implanted devices	0.003	0.997	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.000	0.997	0.003
R87.6 Abnormal cytological findings	0.000	0.997	0.003
M10.9 Gout, unspecified	0.003	0.997	0.000
E16 Other disorders of pancreatic internal secretion	0.000	0.997	0.003
C50.2 Upper-inner quadrant of breast	0.003	0.997	0.000
H43-H45 Disorders of vitreous body and globe	0.000	0.997	0.003
Z90.1 Acquired absence of breast(s)	0.003	0.997	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.000	0.997	0.003
E14.9 Without complications	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
A41.8 Other specified septicaemia	0.000	0.997	0.003
C50.1 Central portion of breast	0.003	0.997	0.000
K57.3 Diverticular disease of large intestine without perforation or abscess	0.003	0.997	0.000
M79.66 Pain in limb (Lower leg)	0.000	0.997	0.003
S42.2 Fracture of upper end of humerus	0.000	0.997	0.003
I27.0 Primary pulmonary hypertension	0.003	0.997	0.000
C34.8 Overlapping lesion of bronchus and lung	0.000	0.997	0.003
C34.2 Middle lobe, bronchus or lung	0.000	0.997	0.003
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.997	0.002
N87.1 Moderate cervical dysplasia	0.003	0.997	0.000
C34.0 Main bronchus	0.000	0.997	0.003
C67.9 Bladder, unspecified	0.003	0.997	0.000
I27.8 Other specified pulmonary heart diseases	0.003	0.997	0.000
I27 Other pulmonary heart diseases	0.003	0.997	0.000
A41.4 Septicaemia due to anaerobes	0.000	0.997	0.002
A41.3 Septicaemia due to Haemophilus influenzae	0.000	0.997	0.002
A41.2 Septicaemia due to unspecified staphylococcus	0.000	0.997	0.002
M06.8 Other specified rheumatoid arthritis	0.000	0.997	0.002
M06.4 Inflammatory polyarthropathy	0.000	0.997	0.002
M06.2 Rheumatoid bursitis	0.000	0.997	0.002
M06.1 Adult-onset Still's disease	0.000	0.997	0.002
Y40 Systemic antibiotics	0.002	0.997	0.000
M13.90 Arthritis, unspecified (Multiple sites)	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.002	0.997	0.000
I27.9 Pulmonary heart disease, unspecified	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.000	0.998	0.002
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Z45.0 Adjustment and management of cardiac pacemaker	0.002	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M24.03 Loose body in joint (Forearm)	0.002	0.998	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
I27.2 Other secondary pulmonary hypertension	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
M10.98 Gout, unspecified (Other)	0.002	0.998	0.000
M10.95 Gout, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M10.94 Gout, unspecified (Hand)	0.002	0.998	0.000
M10.93 Gout, unspecified (Forearm)	0.002	0.998	0.000
M10.92 Gout, unspecified (Upper arm)	0.002	0.998	0.000
M10.91 Gout, unspecified (Shoulder region)	0.002	0.998	0.000
M10.90 Gout, unspecified (Multiple sites)	0.002	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
Y57 Other and unspecified drugs and medicaments	0.002	0.998	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.000	0.998	0.002
E14.3 With ophthalmic complications	0.002	0.998	0.000
E16.9 Disorder of pancreatic internal secretion, unspecified	0.000	0.998	0.002
E16.8 Other specified disorders of pancreatic internal secretion	0.000	0.998	0.002
E16.4 Abnormal secretion of gastrin	0.000	0.998	0.002
E16.3 Increased secretion of glucagon	0.000	0.998	0.002
E16.1 Other hypoglycaemia	0.000	0.998	0.002
E16.0 Drug-induced hypoglycaemia without coma	0.000	0.998	0.002
H45 Disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.998	0.002
M13.97 Arthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
Y57.5 X-ray contrast media	0.002	0.998	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
M24.0 Loose body in joint	0.002	0.998	0.000
L60 Nail disorders	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.7 Peripheral vasodilators	0.002	0.998	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.000	0.998	0.002
O36.5 Maternal care for poor foetal growth	0.000	0.998	0.002
A49.8 Other bacterial infections of unspecified site	0.000	0.998	0.002
M25.6 Stiffness of joint, not elsewhere classified	0.002	0.998	0.000
S42.21 Fracture of upper end of humerus (open)	0.000	0.998	0.002
Y40.0 Penicillins	0.002	0.998	0.000
K04.6 Periapical abscess with sinus	0.002	0.998	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.000	0.998	0.002
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
H25.8 Other senile cataract	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
M24.07 Loose body in joint (Ankle and foot)	0.002	0.998	0.000
M25.62 Stiffness of joint, not elsewhere classified (Upper arm)	0.002	0.998	0.000
I27.1 Kyphoscoliotic heart disease	0.002	0.998	0.000
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.998	0.002
M06.18 Adult-onset Still's disease (Other)	0.000	0.998	0.002
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.998	0.002
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.998	0.002
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.998	0.002
M06.14 Adult-onset Still's disease (Hand)	0.000	0.998	0.002
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.998	0.002
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.998	0.002
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.998	0.002
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.998	0.002
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.998	0.002
M06.28 Rheumatoid bursitis (Other)	0.000	0.998	0.002
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.998	0.002
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.998	0.002
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.998	0.002
M06.24 Rheumatoid bursitis (Hand)	0.000	0.998	0.002
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.998	0.002
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.998	0.002
M06.21 Rheumatoid bursitis (Shoulder region)	0.000	0.998	0.002
M06.20 Rheumatoid bursitis (Multiple sites)	0.000	0.998	0.002
M06.49 Inflammatory polyarthropathy (Site unspecified)	0.000	0.998	0.002
M06.48 Inflammatory polyarthropathy (Other)	0.000	0.998	0.002
M06.47 Inflammatory polyarthropathy (Ankle and foot)	0.000	0.998	0.002
M06.46 Inflammatory polyarthropathy (Lower leg)	0.000	0.998	0.002
M06.45 Inflammatory polyarthropathy (Pelvic region and thigh)	0.000	0.998	0.002
M06.44 Inflammatory polyarthropathy (Hand)	0.000	0.998	0.002
M06.43 Inflammatory polyarthropathy (Forearm)	0.000	0.998	0.002
M06.42 Inflammatory polyarthropathy (Upper arm)	0.000	0.998	0.002
M06.41 Inflammatory polyarthropathy (Shoulder region)	0.000	0.998	0.002
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.998	0.002
M06.89 Other specified rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
R61.9 Hyperhidrosis, unspecified	0.000	0.998	0.002
N39 Other disorders of urinary system	0.002	0.998	0.000
M13.94 Arthritis, unspecified (Hand)	0.002	0.998	0.000
E14 Unspecified diabetes mellitus	0.002	0.998	0.000
M25.66 Stiffness of joint, not elsewhere classified (Lower leg)	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y40.6 Rifamycins	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y40.3 Macrolides	0.002	0.998	0.000
Y40.2 Chloramphenicol group	0.002	0.998	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
M06.39 Rheumatoid nodule (Site unspecified)	0.000	0.998	0.002
M06.38 Rheumatoid nodule (Other)	0.000	0.998	0.002
M06.37 Rheumatoid nodule (Ankle and foot)	0.000	0.998	0.002
M06.36 Rheumatoid nodule (Lower leg)	0.000	0.998	0.002
M06.35 Rheumatoid nodule (Pelvic region and thigh)	0.000	0.998	0.002
M06.33 Rheumatoid nodule (Forearm)	0.000	0.998	0.002
M06.32 Rheumatoid nodule (Upper arm)	0.000	0.998	0.002
M06.31 Rheumatoid nodule (Shoulder region)	0.000	0.998	0.002
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
H44 Disorders of globe	0.000	0.998	0.002
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.002	0.998	0.000
M25.67 Stiffness of joint, not elsewhere classified (Ankle and foot)	0.002	0.998	0.000
H81.0 Meniere's disease	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.002	0.998	0.000
N39.8 Other specified disorders of urinary system	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Y57.7 Vitamins, not elsewhere classified	0.002	0.998	0.000
Y57.6 Other diagnostic agents	0.002	0.998	0.000
Y57.4 Pharmaceutical excipients	0.002	0.998	0.000
Y57.3 Alcohol deterrents	0.002	0.998	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.002	0.998	0.000
Y57.1 Lipotropic drugs	0.002	0.998	0.000
Y57.0 Appetite depressants [anorectics]	0.002	0.998	0.000
M25 Other joint disorders, not elsewhere classified	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
M10.97 Gout, unspecified (Ankle and foot)	0.002	0.998	0.000
H45.8 Other disorders of vitreous body and globe in diseases classified elsewhere	0.000	0.998	0.002
H45.1 Endophthalmitis in diseases classified elsewhere	0.000	0.998	0.002
H45.0 Vitreous haemorrhage in diseases classified elsewhere	0.000	0.998	0.002
M10 Gout	0.002	0.998	0.000
M06.34 Rheumatoid nodule (Hand)	0.000	0.998	0.002
M24.02 Loose body in joint (Upper arm)	0.002	0.998	0.000
M25.87 Other specified joint disorders (Ankle and foot)	0.002	0.998	0.000
M25.86 Other specified joint disorders (Lower leg)	0.002	0.998	0.000
M25.8 Other specified joint disorders	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
A49 Bacterial infection of unspecified site	0.000	0.998	0.002
M24 Other specific joint derangements	0.002	0.998	0.000
C67.1 Dome of bladder	0.002	0.998	0.000
L60.9 Nail disorder, unspecified	0.000	0.998	0.002
L60.5 Yellow nail syndrome	0.000	0.998	0.002
L60.4 Beau's lines	0.000	0.998	0.002
L60.3 Nail dystrophy	0.000	0.998	0.002
L60.2 Onychogryphosis	0.000	0.998	0.002
L60.1 Onycholysis	0.000	0.998	0.002
Z45 Adjustment and management of implanted device	0.002	0.998	0.000
M24.09 Loose body in joint (Site unspecified)	0.002	0.998	0.000
M24.08 Loose body in joint (Other)	0.002	0.998	0.000
M24.06 Loose body in joint-Lower leg	0.002	0.998	0.000
M24.05 Loose body in joint (Pelvic region and thigh)	0.002	0.998	0.000
M24.04 Loose body in joint (Hand)	0.002	0.998	0.000
M24.01 Loose body in joint (Shoulder region)	0.002	0.998	0.000
M24.00 Loose body in joint (Multiple sites)	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
M25.69 Stiffness of joint, not elsewhere classified (Site unspecified)	0.002	0.998	0.000
M25.68 Stiffness of joint, not elsewhere classified (Other)	0.002	0.998	0.000
M25.65 Stiffness of joint, not elsewhere classified (Pelvic region and thigh)	0.002	0.998	0.000
M25.64 Stiffness of joint, not elsewhere classified (Hand)	0.002	0.998	0.000
M25.63 Stiffness of joint, not elsewhere classified (Forearm)	0.002	0.998	0.000
M25.61 Stiffness of joint, not elsewhere classified (Shoulder region)	0.002	0.998	0.000
M25.60 Stiffness of joint, not elsewhere classified (Multiple sites)	0.002	0.998	0.000
C34.1 Upper lobe, bronchus or lung	0.000	0.998	0.002
S42 Fracture of shoulder and upper arm	0.000	0.998	0.002
B98.0 Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters	0.002	0.998	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.002	0.998	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.002	0.998	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.002	0.998	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.002	0.998	0.000
Y51.0 Anticholinesterase agents	0.002	0.998	0.000
S42.10 Fracture of scapula (closed)	0.000	0.998	0.002
S42.1 Fracture of scapula	0.000	0.998	0.002
Z93.0 Tracheostomy status	0.002	0.998	0.000
M25.77 Osteophyte (Ankle and foot)	0.002	0.998	0.000
M13.9 Arthritis, unspecified	0.002	0.998	0.000
M24.2 Disorder of ligament	0.002	0.998	0.000
H74 Other disorders of middle ear and mastoid	0.002	0.998	0.000
M21.27 Flexion deformity (Ankle and foot)	0.002	0.998	0.000
M25.7 Osteophyte	0.002	0.998	0.000
N39.2 Orthostatic proteinuria, unspecified	0.002	0.998	0.000
N39.1 Persistent proteinuria, unspecified	0.002	0.998	0.000
A49.0 Staphylococcal infection, unspecified	0.000	0.998	0.002
E14.8 With unspecified complications	0.002	0.998	0.000
E14.7 With multiple complications	0.002	0.998	0.000
E14.6 With other specified complications	0.002	0.998	0.000
E14.5 With peripheral circulatory complications	0.002	0.998	0.000
E14.4 With neurological complications	0.002	0.998	0.000
E14.2 Withrenal complications	0.002	0.998	0.000
E14.1 With ketoacidosis	0.002	0.998	0.000
E14.0 With coma	0.002	0.998	0.000
M24.5 Contracture of joint	0.002	0.998	0.000
M25.3 Other instability of joint	0.002	0.998	0.000
S42.4 Fracture of lower end of humerus	0.000	0.998	0.002
C50 Malignant neoplasm of breast	0.002	0.998	0.000
M13.93 Arthritis, unspecified (Forearm)	0.002	0.998	0.000
H74.4 Polyp of middle ear	0.002	0.998	0.000
L60.8 Other nail disorders	0.000	0.998	0.002
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
C67 Malignant neoplasm of bladder	0.002	0.998	0.000
H81 Disorders of vestibular function	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
A30-A49 Other bacterial diseases	0.000	0.998	0.002
C50.6 Axillary tail of breast	0.002	0.998	0.000
H44.9 Disorder of globe, unspecified	0.000	0.998	0.001
H44.8 Other disorders of globe	0.000	0.998	0.001
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.000	0.998	0.001
H44.6 Retained (old) intraocular foreign body, magnetic	0.000	0.998	0.001
H44.5 Degenerated conditions of globe	0.000	0.998	0.001
H44.4 Hypotony of eye	0.000	0.998	0.001
H44.3 Other degenerative disorders of globe	0.000	0.998	0.001
H44.1 Other endophthalmitis	0.000	0.998	0.001
H44.0 Purulent endophthalmitis	0.000	0.998	0.001
M25.0 Haemarthrosis	0.002	0.998	0.000
S61.0 Open wound of finger(s) without damage to nail	0.000	0.998	0.002
Y46.8 Antispasticity drugs	0.002	0.998	0.000
Y46.7 Anti-Parkinsonism drugs	0.002	0.998	0.000
Y46.6 Other and unspecified antiepileptics	0.002	0.998	0.000
Y46.5 Valproic acid	0.002	0.998	0.000
Y46.4 Iminostilbenes	0.002	0.998	0.000
Y46.3 Deoxybarbiturates	0.002	0.998	0.000
Y46.2 Hydantoin derivatives	0.002	0.998	0.000
Y46.1 Oxazolidinediones	0.002	0.998	0.000
Y46.0 Succinimides	0.002	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.002	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.002	0.998	0.000
Y47.4 Bromine compounds	0.002	0.998	0.000
Y47.3 Paraldehyde	0.002	0.998	0.000
Y47.2 Chloral derivatives	0.002	0.998	0.000
Y47.1 Benzodiazepines	0.002	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
Y49.9 Psychotropic drug, unspecified	0.002	0.998	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
Y49.7 Psychostimulants with abuse potential	0.002	0.998	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.002	0.998	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.002	0.998	0.000
Y49.2 Other and unspecified antidepressants	0.002	0.998	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.002	0.998	0.000
Y50.8 Other central nervous system stimulants	0.002	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.002	0.998	0.000
Y50.1 Opioid receptor antagonists	0.002	0.998	0.000
Y50.0 Analeptics	0.002	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y53.7 Emetics	0.002	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.998	0.000
Y53.5 Digestants	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.998	0.000
Y53.2 Stimulant laxatives	0.002	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.002	0.998	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.002	0.998	0.000
Y55.5 Anticommon cold drugs	0.002	0.998	0.000
Y55.4 Expectorants	0.002	0.998	0.000
Y55.3 Antitussives	0.002	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.002	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.002	0.998	0.000
Y55.0 Oxytocic drugs	0.002	0.998	0.000
Y56.9 Topical agent, unspecified	0.002	0.998	0.000
Y56.8 Other topical agents	0.002	0.998	0.000
Y56.7 Dental drugs, topically applied	0.002	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.002	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.002	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.002	0.998	0.000
Y56.3 Emollients, demulcents and protectants	0.002	0.998	0.000
Y56.2 Local astringents and local detergents	0.002	0.998	0.000
Y56.1 Antipruritics	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.002	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.002	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.002	0.998	0.000
Y58.5 Diphtheria vaccine	0.002	0.998	0.000
Y58.4 Tetanus vaccine	0.002	0.998	0.000
Y58.3 Plague vaccine	0.002	0.998	0.000
Y58.2 Cholera vaccine	0.002	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Y59.9 Vaccine or biological substance, unspecified	0.002	0.998	0.000
Y59.8 Other specified vaccines and biological substances	0.002	0.998	0.000
Y59.3 Immunoglobulin	0.002	0.998	0.000
Y59.2 Protozoal vaccines	0.002	0.998	0.000
Y59.1 Rickettsial vaccines	0.002	0.998	0.000
Y59.0 Viral vaccines	0.002	0.998	0.000
S42.40 Fracture of lower end of humerus (closed)	0.000	0.998	0.002
H81.1 Benign paroxysmal vertigo	0.002	0.998	0.000
M20.5 Other deformities of toe(s) (acquired)	0.002	0.998	0.000
M25.9 Joint disorder, unspecified	0.002	0.998	0.000
M25.4 Effusion of joint	0.002	0.998	0.000
M25.2 Flail joint	0.002	0.998	0.000
M25.1 Fistula of joint	0.002	0.998	0.000
R87 Abnormal findings in specimens from female genital organs	0.000	0.998	0.002
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
M24.27 Disorder of ligament (Ankle and foot)	0.002	0.998	0.000
M25.89 Other specified joint disorders (Site unspecified)	0.002	0.998	0.000
M25.88 Other specified joint disorders (Other)	0.002	0.998	0.000
M25.83 Other specified joint disorders (Forearm)	0.002	0.998	0.000
M25.82 Other specified joint disorders (Upper arm)	0.002	0.998	0.000
M25.81 Other specified joint disorders (Shoulder region)	0.002	0.998	0.000
M25.80 Other specified joint disorders (Multiple sites)	0.002	0.998	0.000
A49.9 Bacterial infection, unspecified	0.000	0.998	0.002
A49.3 Mycoplasma infection, unspecified	0.000	0.998	0.002
A49.2 Haemophilus influenzae infection, unspecified	0.000	0.998	0.002
C50.8 Overlapping lesion of breast	0.002	0.998	0.000
E87.1 Hypo-osmolality and hyponatraemia	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations